niacinamide has been researched along with Dermatitis, Exfoliative in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Dermatitis, Exfoliative: The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib treatment was initiated a 400 mg orally twice a day." | 1.35 | Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome. ( Borrás-Blasco, J; Casterá, ME; Galán Brotons, A; Rosique-Robles, JD; Vicent Verge, JM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galán Brotons, A | 1 |
| Borrás-Blasco, J | 1 |
| Rosique-Robles, JD | 1 |
| Vicent Verge, JM | 1 |
| Casterá, ME | 1 |
1 review available for niacinamide and Dermatitis, Exfoliative
| Article | Year |
|---|---|
Sorafenib (Nexavar) for thyroid cancer.
Topics: Animals; Antineoplastic Agents; Dermatitis, Exfoliative; Humans; Niacinamide; Phenylurea Compounds; | 2014 |
1 other study available for niacinamide and Dermatitis, Exfoliative
| Article | Year |
|---|---|
Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Dermatitis, Exfoliative; Drug Erupt | 2008 |